AliveDx receives three IVDR CE marks for its Multiplexed Autoimmune Diagnostics Solution

AliveDx Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

for more information.

About AliveDx

At AliveDx, we empower diagnostic insights, transform patient care, and innovate for life. With over 30-years in in-vitro diagnostics, we put the health of patients first by creating innovative solutions designed for faster disease detection to shorten the time to diagnosis. Alba – our blood bank reagents portfolio – and MosaiQ® – one of the first multiplexing and multimodality automated testing platforms – are designed to make laboratories more efficient and clinical decision-making more effective. Our journey started as Alba Bioscience, and later, Quotient. Today, as AliveDx, we innovate for life.

©AliveDx Holdings Finance Company Ltd, 2023. MosaiQ is a trademark or registered trademark of AliveDx Holdings Finance Company Limited or its subsidiaries in various jurisdictions. Menus and capabilities are subject to change. Not all methods may be available in all territories. Subject to regulatory clearance.

View original content:https://www.prnewswire.co.uk/news-releases/alivedx-receives-three-ivdr-ce-marks-for-its-multiplexed-autoimmune-diagnostics-solution-301970413.html